Sign In
Buy APG
$41.98
-0.410 (-0.97%)
At Close: Jun 05, 2026
APi Group to Webcast 2025 Investor Day Live on May 21, 2025
07:30am, Wednesday, 07'th May 2025
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced it will webcast its 2025 Investor Day beginning at 9:00 a.m. ET on Wednesday, M
APi Group Corporation (APG) Q1 2025 Earnings Call Transcript
03:10pm, Thursday, 01'st May 2025
APi Group Corporation (NYSE:APG ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Adam Fee – Vice President of Investor Relations Russ Becker – President and Chief Exe
APi (APG) Reports Q1 Earnings: What Key Metrics Have to Say
10:36am, Thursday, 01'st May 2025
While the top- and bottom-line numbers for APi (APG) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wal
APi (APG) Q1 Earnings and Revenues Beat Estimates
09:45am, Thursday, 01'st May 2025
APi (APG) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.34 per share a year ago.
APi Group Reports First Quarter 2025 Financial Results
07:30am, Thursday, 01'st May 2025
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today reported its financial results for the three months ended March 31, 2025. Russ Becker, AP
APi Group Confirms Date of First Quarter 2025 Earnings Release
07:30am, Thursday, 17'th Apr 2025
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) announced today that it intends to release its financial results for the three months ended Mar
Apogee Therapeutics: Engineering Biologic Dominance
08:04am, Monday, 14'th Apr 2025
Apogee's strong financial position, with $731.1 million in cash, funds operations through Q1 2028, de-risking its ambitious pipeline development in inflammatory diseases. Significant R&D investments i
APi Group Appoints David Jackola Executive Vice President & Chief Financial Officer
07:30am, Monday, 31'st Mar 2025
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced the appointment of David Jackola as Executive Vice President & Chief Financial
APi Group Announces Participation in the 2025 J.P. Morgan Industrials Conference
07:30am, Friday, 07'th Mar 2025
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi”) today announced that its senior leadership will be participating in a fireside chat during the 2025 J.P. Morgan Indu
APi Group: Rating Downgrade As I Am Not Confident On FY25 Performance
09:23am, Tuesday, 04'th Mar 2025
I am downgrading APi Group (APG) to hold due to uncertain near-term performance, weak organic growth, and macro uncertainties impacting FY25 outlook. Despite solid 4Q24 adj EBITDA growth and a healthy
Interim Phase 1 results for APG990, a novel half-life extended OX40L antibody, exceeded trial objectives and demonstrated an approximately 60-day half-life
SAN FRANCISCO and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiate
APi Group Corporation (APG) Q4 2024 Earnings Call Transcript
03:10pm, Wednesday, 26'th Feb 2025
APi Group Corporation (NYSE:APG ) Q4 2024 Earnings Conference Call February 26, 2025 8:30 AM ET Company Participants Adam Fee - Vice President, Investor Relations Russell Becker - President and Chief
APi (APG) Reports Q4 Earnings: What Key Metrics Have to Say
10:36am, Wednesday, 26'th Feb 2025
The headline numbers for APi (APG) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
APi (APG) Q4 Earnings and Revenues Beat Estimates
09:45am, Wednesday, 26'th Feb 2025
APi (APG) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.44 per share a year ago.
